National Cancer Institute, European Liaison Office
Brussels, Belgium

The NCI European Liaison Office in Brussels, Belgium coordinates several of the Institute’s research and treatment programs in Europe through formal agreements with the EORTC, the British Cancer Research UK (CRUK) and the Southern Europe New Drugs Organization (SENDO), as well as with other European cancer research institutes and laboratories and pharmaceutical/chemical industries. Its aim is to facilitate the exchange of information, experimental drugs, research protocols, scientists, and scientific expertise between the NCI and its European collaborators. The Office gathers, reviews and subsequently submits European cancer research protocols for inclusion in NCI’s clinical database PDQ/CancerNet, which is distributed worldwide through various channels. It participates on numerous European committees and in working groups involved in new drug development, as well as on the EORTC Board and Council and the CRUK PhI/II clinical trials committee. It is also an observer on the European Drug Development Network (EDDN),and supports an international exchange of experimental drugs for pre-clinical and clinical evaluation. Closer interactions have recently been established with the International Network for Cancer Research & Treatment INCTR, whereby the NCI L.O. assists with some of the training and education activities supported by the NCI’s OIA. Furthermore, the NCI L.O. is the European hub for NCI’s TELESYNERGY® Medical Consultation WorkStation and coordinates its use for international conferences.

Equipment installed at this site: Full TELESYNERGY(R) system using off-the-shelf software on a Windows XP Workstation.